Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

South Africa Launches HIV/AIDS Research Initiative
South Africa"s Science and Technology Minister Naledi Pandor on Tuesday announced a government-sponsored research initiative that "aims to combat HIV and AIDS through scientific and technological research, the development of new drugs, diagnostic tests and vaccines," SAPA/IOL reports (7/28). "[K]ey focus areas" of the South Africa HIV/AIDS Research and Innovation Platform (SHARP) will be prevention and therapeutics, according to BuaNews (7/28).

Low Oxygen Levels In Prostate Tumors Can Predict Recurrence: Long-Term Study
Fox Chase Cancer Center researchers have discovered that low-oxygen regions in prostate tumors can be used to predict a rise in prostate-specific antigen (PSA) levels, a marker of tumor recurrence in prostate cancer. The long-term study results were presented at the 2009 American Society of Clinical Oncology annual meeting in Orlando, FL.
News of the day
Only Drop-In Needle Exchange Center In Minnesota Closes Due To Lack Of Funding
Minnesota"s only storefront needle exchange drop-in center, called Access Works!, "fell victim to economic hard times and federal anti-drug policies" and ended its program last week after 13 years, the Minnesota Independent reports. The program "traded used needles for clean ones, conducted HIV and Hepatitis C testing, taught overdose prevention, held support groups and connected users with chemical dependency treatment experts," according to the Independent. Federal funding cannot be used to administer needles for such programs, Lauri Wollner, executive director of the program said. She added, "The federal ban has had a long-term impact. We spend almost $40,000 a year on needles and about $5,000 a year on disposal (of used needles)." Private donations also have been down, she said. While the ban on the use of federal funding for needle exchange is being revisited by Congress, "local needle-exchange activists say it is doubtful that congressional action will be able to save the struggling organization," the article states (Birkey, 8/3).
Oncology

The Integration Of The Nellcor™ OxiMax™ SpO2 System Into Philips Patient Monitors Announced By Covidien

Covidien (NYSE: COV), a leading global supplier of healthcare products, has announced the integration of its Nellcor™ OxiMax™ oximetry system into Philips IntelliVue and M-Series patient monitors. Philips is a leading global provider of patient monitoring solutions, and the collaboration between the companies is expected to significantly increase, in all major geographies, hospitals" and healthcare providers" access to the industry-leading capabilities offered by both companies. Customers will have the added flexibility of choosing the Nellcor OxiMax technology in Philips IntelliVue and M-Series patient monitors for critical care areas such as the Intensive Care, Emergency, Anesthesia and Neonatal Care departments. This enables the IntelliVue and M-Series patient monitors to be compatible with Covidien"s Nellcor OxiMax specialty sensors, including the Max-Fast™ forehead sensor for patients with poor perfusion and the SoftCare™ nonadhesive sensor line for patients with sensitive skin, including newborns. In the intensive care unit and other high-acuity areas of the hospital, Max-Fast and SoftCare sensors support effective, comfortable care for the most critical patients. "Hospitals and clinicians are under constant pressure to improve outcomes and decrease costs. In turn, they are demanding expanded access to the technologies and medical devices they trust," said Chris Lowery, General Manager and Vice President, Patient Monitoring, Covidien. "Covidien"s partnership with Philips gives hospitals access to advanced technology from two leading medical monitoring companies. The successful completion of this collaboration with Philips, a recognized industry leader in patient monitoring, is consistent with Covidien"s mission to provide products that help clinicians deliver safe and efficacious patient care, while simultaneously maximizing hospital efficiency." "Many clinicians have expressed great interest in Nellcor OxiMax technology in our IntelliVue patient monitors," said David Russell, Vice President and Chief Marketing Officer, Informatics and Patient Monitoring, Philips Healthcare. "This collaboration enhances our ability to provide customers in the USA, Europe and many other markets with a choice of their preferred trusted pulse oximetry technology. This partnership also underscores Philips" commitment to providing clear, accurate information to support clinical decision-making across all areas of the hospital." Katherine Tripple Feinstein Kean Healthcare


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009